Navigation Links
Antipsychotic Iloperidone Results Show Favorable Akathisia Profile

tients taking antipsychotics discontinued treatment within 18 months, primarily because of insufficient efficacy and tolerability issues.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., headquartered in Rockville, Maryland, is a biopharmaceutical company working to advance the science of personalized medicine to improve the lives of patients with schizophrenia. The company has three product candidates in clinical development. Vanda's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia and has completed its Phase III program. Vanda's second product candidate, VEC- 162, is a compound for the treatment of sleep and mood disorders which is currently in Phase III for insomnia. Vanda's third product candidate, VSF-173, is a compound for the treatment of excessive sleepiness and is ready for a Phase II clinical trial. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Note Regarding Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Words such as, but not limited to, "suggest," "look forward to," "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "may," "would," "should," and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include, among others, a failure of iloperidone or Vanda's other product candidates to be demonstrably safe and effective, a failure to obtain regulatory approval for iloperidone or the company's other product candidates, a lack of acceptance
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
2. Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007 American Psychiatric Association Annual Meeting
3. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
4. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis

Post Your Comments:
(Date:11/23/2009)...ewswire-FirstCall/--BeckmanCoulter,Inc.(NYSE: BEC ...uctsthatsimplify,automate,andinnovatecomplexbiomed...oulter,svicepresidentofstrategy,willpresentatthePi...2,2009at12:00p.m.(ET). ,, (Logo: http://www.new...livewebcastofBeckmanCoulter,spresentationcanbeacce...
(Date:11/23/2009)...portlinker.comannouncesthatanewmarketresearchrepor...CSandEMR ,, http://www.reportlinker.com/p016...newswire&utm_medium=pr&utm_campaign=prnews...lmost$1.3billion,representinganincreaseof6.7%over2...mediumhospitals(201-499beds),communityhospitals(20...
(Date:11/23/2009)...portlinker.comannouncesthatanewmarketresearchrepor...Disposables-AWorldwideMarketReview ,, http:/...sposables---A-Worldwide-Market-Review.html#utm_sou...prnewswire ,, Withincreaseinrangeofinfectio...ndhospitalfacilities,nonwovenshasemergedasagoldmin...
Breaking Medicine Technology:Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 56563 1Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 56563 2Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 56563 3Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 56563 4FiLife Announces New Twitter Contest on Fixing the American Healthcare System 56561 1FiLife Announces New Twitter Contest on Fixing the American Healthcare System 56561 2XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor Naturally 56559 1XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor Naturally 56559 2XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor Naturally 56559 3
...zerland, July 3, 2007 - Cytos Biotechnology,AG (SW...tudy with,CYT003-QbG10 in atopic dermatitis. CYT00...currently in development for,the treatment of alle...afety, tolerability and exploratory efficacy of th...opic dermatitis. The study,was designed as a place...
...y 5 /PRNewswire-FirstCall/ -- Nuvelo,Inc. (Nasdaq...(Anticoagulation with rNAPc2 To Help Eliminate MAC...matode anticoagulant protein c2,(rNAPc2) in patien...l data evaluating rNAPc2 in mouse models of colore...echanism of NU172, a,short-acting, direct thrombin...
Other Medicine Technology:Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis 2Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis 3Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis 4Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis 5Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 2Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 3
(Date:11/24/2009)... Web content and Internet marketin...ee leads through your website. , ... another tough year for the U.S. economy. Small bu... the strain to keep their businesses afloat and re...ing block are things like training or marketing pr...
(Date:11/24/2009)...ESTON,Va.,Nov.24/PRNewswire/--LincolnCountyHeathca...withtwosmallhospitalsandretirementcommunities,empl...fyou,reanITpersonandyou,renotgettingsuccessfulback...identofInformationServicesatLCH.Asisthecasewithman...utBettsknewheneededabackupredesigntoprotecthismiss...
(Date:11/24/2009)...ARRYTOWN,N.Y.,Nov.24/PRNewswire-FirstCall/--Regene...tspresentationatthe21stAnnualPiperJaffrayHealthcar...nisscheduledfor4:00p.m.EasternTime.Thesessionmaybe...com ,ontheInvestorRelationspage.Anarchivedversiono...throughDecember31,2009.AdditionalinformationaboutR...
(Date:11/24/2009)...who had at least one child were less likely to bec...Nov. 24 (HealthDay News) -- Having children may sl...arch suggests. , Belgian researchers followed ...oms between the ages of 22 and 38. , Women who ...ent less likely to have the disease progress to a ...
(Date:11/24/2009)...EL-AVIV,Israel,November24/PRNewswire-FirstCall/--I...chemicalscompany,todayreported,resultsforthethirdq...inancialResultsfortheThirdQuarter , Revenues:...up,24%ascomparedsequentiallywith$1,083millionforth...2008were$2,178million,reflecting,theexceptionaldem...
Breaking Medicine News(10 mins):Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7
...developed new tests that would determiner the auth...lebrating Cinco de Mayo or just having another rel...distinguish the real thing from fraudulent version...he estimated billion-dollar tequila market, the re...
...s latest blueprint for handling a pandemic, state ...r coordinating// the battle against an outbreak of...have been laid by the federal government to decrea... A preliminary $7.1 billion plan was released i...
...ld kid from Orissa is winning many hearts and seem...dia is raving about his incredible stamina and pre... Two days back Budhia ran a distance of 65 km, s...ds. He further intends to participate at the Londo...
...ng blamed on the beverage industy, three major sof... sugary soft drinks// with low-calorie or nutriti...althier Generation. a joint initiative of the Will...n Beverage Association, a trade group. Accordi...
...he health of people living in Africa is well known...tive impact on health// of women and children, inc... under the insecticide-treated nets. Infact expect...arasites are most active at night. The pest-killin...
... Hospital in Boston have established via a study, ...g recurrent ovarian cancer// , which is perhaps ev...sively. The researchers analyzed 54 body CT,...nstrated an improved accuracy (49/53, 92%) over CT...
Other Medicine News:Health News:Tequila-The Real Stuff or Not 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 3Health News:Save Budhia - The Indian Wonder Kid 2Health News:Save Budhia - The Indian Wonder Kid 3Health News:Save Budhia - The Indian Wonder Kid 4Health News:Nutritious Beverages to be Sold in School 2Health News:Health of Mothers and Children Show Improvement after Use of Insecticide-Treated Bed Nets 2Health News:Health of Mothers and Children Show Improvement after Use of Insecticide-Treated Bed Nets 3
...-Step LH Ovulation Tests are qualitative immunoass...ormone (LH) in urine. The procedure is fast and re...ears and is darker than the control band, then ovu.... If the test band does not appear or is lighter ...
SureStep Fertility
HemoSite® Meter
The Clinitek® 50 analyzer
Medicine Products: